Delivery Order SPE2DB25D3201-SPE2DB25FNNLB
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,233.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Paclitaxel Protein-Bound 100MG, a specialty medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Paclitaxel 300 mg/50 ml vial, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that the company holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,611.40 firm fixed-price delivery order is for the supply of 4557853847 - Paclitaxel 300 mg/50 ml vial, 50 ml. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,489.85 firm fixed-price delivery order is for the supply of PACLITAXEL PROTEIN-BOUND 100MG, a pharmaceutical product, with a performance period through February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Paclitaxel Protein-Bound 100MG to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 8, 2025, with a ceiling value of $6,457.44 and a completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,264.00, is for the delivery of 4567272477 - DOCETAXEL 160 MG/16 ML VIAL 16ML. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 160 mg/16 ml docetaxel vials. The contract has a ceiling value of $2,800.08 and runs from August 2022 to August 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide...
This federal contract award, valued at $2,771.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PADCEV 30 MG VIALS, with a firm fixed price and an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $7,797.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, valued at $2,150.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of medical products, including specialty medications, brand-name and generic drugs,...